Moreover, by using fluorescent-labeling HDGF, the cellular uptake assay revealed that prior NCL blockage significantly depleted the fluorescence in HDGF-treated hepatoma cells (Figure 3B). This evidence concerns the gene HDGF and hepatocellular carcinoma.